YIELD10 BIOSCIENCE, INC. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Yield10 Bioscience, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2017 to 2023.
  • Yield10 Bioscience, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $1.21M, a 759% increase year-over-year.
  • Yield10 Bioscience, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $6.87M.
  • Yield10 Bioscience, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$37K, a 100% decline from 2021.
  • Yield10 Bioscience, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $15.7M, a 116% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $6.87M +$6.91M Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 -$37K -$15.8M -100% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $15.7M +$8.47M +116% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 $7.28M -$6.8M -48.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-25
2019 $14.1M +$14M +11831% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-16
2018 $118K -$15.2M -99.2% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-25
2017 $15.3M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.